Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nallakkandi Rajeevan

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
The Lancet. Infectious Diseases|January 23, 2025
Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation studyKristina L Bajema, Lei Yan, Yuli Li, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2022
Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomesKristina L Bajema, Kristin Berry, Elani Streja, et al.
Annals of Internal Medicine|June 5, 2023
Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month OutcomesKristina L Bajema, Kristin Berry, Elani Streja, et al.
Annals of Internal Medicine|October 30, 2023
Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among U.S. Veterans : A Target Trial EmulationGeorge N Ioannou, Kristin Berry, Nallakkandi Rajeevan, et al.
Annals of Internal Medicine|February 4, 2025
Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up : A Target Trial EmulationGeorge N Ioannou, Kristin Berry, Nallakkandi Rajeevan, et al.
Human Genomics|June 2, 2023
Modeling the longitudinal changes of ancestry diversity in the Million Veteran ProgramFrank R Wendt, Gita A Pathak, Jacqueline Vahey, et al.
Science (New York, N.Y.)|January 12, 2023
Dome1-JAK-STAT signaling between parasite and host integrates vector immunity and developmentVipin S Rana, Chrysoula Kitsou, Shraboni Dutta, et al.
Nature Neuroscience|July 31, 2019
Genome-wide association study of post-traumatic stress disorder reexperiencing symptoms in >165,000 US veteransJoel Gelernter, Ning Sun, Renato Polimanti, et al.
Biological Psychiatry|June 2, 2019
Genome-wide Association Study of Maximum Habitual Alcohol Intake in >140,000 U.S. European and African American Veterans Yields Novel Risk LociJoel Gelernter, Ning Sun, Renato Polimanti, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 25, 2019
Genome-wide association study of cognitive performance in U.S. veterans with schizophrenia or bipolar disorderPhilip D Harvey, Ning Sun, Tim B Bigdeli, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
The Lancet. Infectious Diseases|January 23, 2025
Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation studyKristina L Bajema, Lei Yan, Yuli Li, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2022
Effectiveness of COVID-19 treatment with nirmatrelvir-ritonavir or molnupiravir among U.S. Veterans: target trial emulation studies with one-month and six-month outcomesKristina L Bajema, Kristin Berry, Elani Streja, et al.
Annals of Internal Medicine|June 5, 2023
Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month OutcomesKristina L Bajema, Kristin Berry, Elani Streja, et al.
Annals of Internal Medicine|October 30, 2023
Effectiveness of Nirmatrelvir-Ritonavir Against the Development of Post-COVID-19 Conditions Among U.S. Veterans : A Target Trial EmulationGeorge N Ioannou, Kristin Berry, Nallakkandi Rajeevan, et al.
Annals of Internal Medicine|February 4, 2025
Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up : A Target Trial EmulationGeorge N Ioannou, Kristin Berry, Nallakkandi Rajeevan, et al.
Human Genomics|June 2, 2023
Modeling the longitudinal changes of ancestry diversity in the Million Veteran ProgramFrank R Wendt, Gita A Pathak, Jacqueline Vahey, et al.
Science (New York, N.Y.)|January 12, 2023
Dome1-JAK-STAT signaling between parasite and host integrates vector immunity and developmentVipin S Rana, Chrysoula Kitsou, Shraboni Dutta, et al.
Nature Neuroscience|July 31, 2019
Genome-wide association study of post-traumatic stress disorder reexperiencing symptoms in >165,000 US veteransJoel Gelernter, Ning Sun, Renato Polimanti, et al.
Biological Psychiatry|June 2, 2019
Genome-wide Association Study of Maximum Habitual Alcohol Intake in >140,000 U.S. European and African American Veterans Yields Novel Risk LociJoel Gelernter, Ning Sun, Renato Polimanti, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 25, 2019
Genome-wide association study of cognitive performance in U.S. veterans with schizophrenia or bipolar disorderPhilip D Harvey, Ning Sun, Tim B Bigdeli, et al.
Pageof 5